The activation of this pathway could imply that BPC-157 plays a role in enhancing the movement and adherence of these cells, which are key processes in tendon healing and regeneration
These results suggest a potential regulatory relationship between thymosin beta 4, microRNA 146a expression, and downstream inflammatory pathway modulation
The peptide has been examined in over 100 published preclinical studies conducted by multiple independent research groups across several countries
Researchers most often study it in animal models of tendon, ligament, gut, and vessel injury
When adverse effects do occur, they are usually mild and transient, often related to the route of administration rather than the vitamin itself
Over the past two decades, research (predominantly in animal models) has expanded to explore its effects on tendon, muscle, bone, nerve, and vascular tissue